Assessment of New Molecular Imaging Strategies for Prostate Cancer: Predictive Value of Established and Novel Positron Emission Tomography (PET) Radiotracers in Castration-Resistant Prostate Cancer
In this study 30 men, with advanced metastatic Castration-Resistant Prostate Cancer (CRPC)
planned to have hormonal treatment, will undergo conventional imaging and functional imaging
prior to treatment and post treatment to determine if changes in imaging results will be
prognostic of outcome. Patients will have a clinical follow-up every 3 months post
randomization for one year and followed for survival at Years 2 and 3.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society